Compare Stocks: BGMS, TLIH, SOS, and JBDI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BGMS Cyclacel Pharmaceuticals	$0.88 +0.8%	$0.88	$0.57 ▼ $8.82	$4.84M	-0.38	945,994 shs	25,107 shs
JBDI JBDI	$1.31 -5.4%	$1.23	$0.78 ▼ $6.00	$12.41M	-1.12	127,346 shs	1,682 shs
SOS SOS	$0.96 +4.8%	$0.97	$0.75 ▼ $2.48	$15.59M	2.62	67,737 shs	176,314 shs
TLIH Ten-League International	$5.73 -1.0%	$5.32	$2.20 ▼ $8.50	$16.85M	N/A	247,850 shs	1,803 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BGMS Cyclacel Pharmaceuticals	+0.62%	-4.25%	-4.86%	-9.79%	+87,049,900.00%
JBDI JBDI	-1.70%	-5.89%	+24.02%	+20.64%	-36.75%
SOS SOS	-5.97%	+5.80%	-7.82%	-14.59%	-46.65%
TLIH Ten-League International	0.00%	+1.58%	+1.58%	+70.80%	-3.50%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BGMS Cyclacel Pharmaceuticals	$0.88 +0.8%	$0.88	$0.57 ▼ $8.82	$4.84M	-0.38	945,994 shs	25,107 shs
JBDI JBDI	$1.31 -5.4%	$1.23	$0.78 ▼ $6.00	$12.41M	-1.12	127,346 shs	1,682 shs
SOS SOS	$0.96 +4.8%	$0.97	$0.75 ▼ $2.48	$15.59M	2.62	67,737 shs	176,314 shs
TLIH Ten-League International	$5.73 -1.0%	$5.32	$2.20 ▼ $8.50	$16.85M	N/A	247,850 shs	1,803 shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BGMS Cyclacel Pharmaceuticals	+0.62%	-4.25%	-4.86%	-9.79%	+87,049,900.00%
JBDI JBDI	-1.70%	-5.89%	+24.02%	+20.64%	-36.75%
SOS SOS	-5.97%	+5.80%	-7.82%	-14.59%	-46.65%
TLIH Ten-League International	0.00%	+1.58%	+1.58%	+70.80%	-3.50%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BGMS Cyclacel Pharmaceuticals	1.00	Sell	N/A	N/A
JBDI JBDI	1.00	Sell	N/A	N/A
SOS SOS	1.00	Sell	N/A	N/A
TLIH Ten-League International	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest BGMS, TLIH, SOS, and JBDI Analyst Ratings

Date	Company	Brokerage	Action	Rating
8/14/2026	JBDI JBDI	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/3/2026	TLIH Ten-League International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D)
7/29/2026	BGMS Cyclacel Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
7/29/2026	JBDI JBDI	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/14/2026	BGMS Cyclacel Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
6/29/2026	TLIH Ten-League International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
6/24/2026	BGMS Cyclacel Pharmaceuticals	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/11/2026	SOS SOS	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 8/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BGMS Cyclacel Pharmaceuticals	$750K	6.46	N/A	N/A	$1.40 per share	0.63
JBDI JBDI	$8.44M	1.47	N/A	N/A	$0.41 per share	3.18
SOS SOS	$154.29M	0.10	N/A	N/A	$26.17 per share	0.04
TLIH Ten-League International	$59.24M	0.28	$2.68 per share	2.14	$4.42 per share	1.30

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BGMS Cyclacel Pharmaceuticals	-$3M	-$3.64	N/A	N/A	N/A	-118.27%	-31.60%	-27.72%	N/A
JBDI JBDI	-$2.72M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SOS SOS	-$97.32M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLIH Ten-League International	$4.34M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest BGMS, TLIH, SOS, and JBDI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2026	Q2 2026	BGMS Cyclacel Pharmaceuticals	N/A	-$0.08	N/A	-$0.08	N/A	$0.34 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BGMS Cyclacel Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
JBDI JBDI	N/A	N/A	N/A	N/A	N/A
SOS SOS	N/A	N/A	N/A	N/A	N/A
TLIH Ten-League International	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BGMS Cyclacel Pharmaceuticals	N/A	8.63	7.22
JBDI JBDI	0.25	4.46	4.19
SOS SOS	N/A	11.05	11.05
TLIH Ten-League International	0.45	0.87	0.56

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BGMS Cyclacel Pharmaceuticals	23.58%
JBDI JBDI	N/A
SOS SOS	1.92%
TLIH Ten-League International	N/A

Insider Ownership

Company	Insider Ownership
BGMS Cyclacel Pharmaceuticals	23.75%
JBDI JBDI	N/A
SOS SOS	2.74%
TLIH Ten-League International	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BGMS Cyclacel Pharmaceuticals	14	5.52 million	4.21 million	N/A
JBDI JBDI	121	9.51 million	N/A	N/A
SOS SOS	170	16.17 million	15.73 million	No Data
TLIH Ten-League International	64	2.94 million	N/A	N/A

BGMS, TLIH, SOS, and JBDI Headlines

Recent News About These Companies

Ten-League International Holdings Limited Announces Grand Opening of Expanded Singapore Headquarters

August 19, 2026 | globenewswire.com

Ten-League Regains Nasdaq Bid Price Compliance, Remains Under One-Year Listing Monitor

June 1, 2026 | tipranks.com

Ten-League International Holdings Limited Regains Compliance with Nasdaq Bid Price Requirement

June 1, 2026 | globenewswire.com

Ten-League International Holdings Limited Reports Fiscal Year 2025 Financial Results

April 30, 2026 | globenewswire.com

Ten-League International Holdings Limited Announces 1-for-10 Reverse Share Split Effective May 1, 2026

April 29, 2026 | globenewswire.com

Ten-League International Wins Shareholder Approval for Flexible Share Consolidation Plan

April 13, 2026 | tipranks.com

Ten-League International Holdings Limited Faces Potential Delisting from Nasdaq Following Non-Compliance with Minimum Bid Price Rule

March 16, 2026 | quiverquant.comQ

Ten-League International Holdings Limited Announces Receipt of Nasdaq Staff Delisting Determination and Plans to Appeal

March 16, 2026 | globenewswire.com

Ten-League International forecasts strong FY2025 growth on Singapore infrastructure momentum

February 24, 2026 | msn.com

Ten-League International Issues Strong FY2025 Guidance on Singapore Infrastructure Demand

February 24, 2026 | tipranks.com

Why Is Ten-League International Holdings Limited Stock (TLIH) Up Today?

February 24, 2026 | tipranks.com

Ten-League International Holdings Limited Announces Fiscal Year 2025 Guidance

February 24, 2026 | globenewswire.com

Ten-League International Holdings Limited Completes Handover of Hydraulic Grabs for Land Transport Authority's Cross Island Line Project

December 19, 2025 | quiverquant.comQ

Ten-League Completes Hydraulic Grab Handover for Singapore’s Cross Island MRT Line

December 19, 2025 | tipranks.com

Ten-League International Holdings Limited Announces Project Handover to Bachy Soletanche Singapore

December 19, 2025 | globenewswire.com

Ten-League International Appoints New Auditor Amid Smooth Transition

December 12, 2025 | tipranks.com

Ten-League Secures New Order from PSA Singapore to Enhance Port Electrification

November 14, 2025 | tipranks.com

Ten-League International Holdings Limited Announces New Order from PSA Singapore to Expand Electrification Program Following Successful BCSS Deployment

November 14, 2025 | globenewswire.com

Ten-League International Reports Strong H1 2025 Revenue Growth

September 30, 2025 | tipranks.com

Ten-League International Holdings Limited Reports Unaudited Financial Results for the First Six Months of Fiscal Year 2025

September 30, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BGMS, TLIH, SOS, and JBDI Company Descriptions

Cyclacel Pharmaceuticals NASDAQ:BGMS

$0.88 +0.01 (+0.76%)

Closing price 03:54 PM Eastern

Extended Trading

$0.88 +0.00 (+0.33%)

As of 04:10 PM Eastern

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced leukemias and solid tumors. Its development programs also comprise Sapacitabine, a novel nucleoside analog that is orally available prodrug of CNDAC, which is in Phase 1/2 clinical trials to treat acute myeloid leukemia and myelodysplastic syndrome; and seliciclib, a CDK inhibitor that is in Phase 2 investigator-sponsored trials (IST) for Cushing's disease, as well as in Phase 1/2 IST for the treatment for advanced rheumatoid arthritis. The company has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. Cyclacel Pharmaceuticals, Inc. is headquartered in Berkeley Heights, New Jersey.

JBDI NASDAQ:JBDI

$1.30 -0.08 (-5.43%)

Closing price 03:16 PM Eastern

Extended Trading

$1.32 +0.02 (+1.15%)

As of 05:14 PM Eastern

JBDI Holdings Limited engages in the trading of reconditioned and recycling containers in Singapore and the Southeast Asia region. The company offers reconditioning and recycling drums, including open top drums, metal drums, plastic drums, plastic carboys, and intermediate bulk containers, as well as new drums, and collects waste drums and related products. It serves solvent, chemical, petroleum, and edible product oil industries. The company was founded in 1983 and is based in Singapore. JBDI Holdings Limited operates as a subsidiary of E U Holdings Pte. Ltd.

SOS NYSE:SOS

$0.96 +0.04 (+4.78%)

Closing price 03:59 PM Eastern

Extended Trading

$0.96 0.00 (-0.41%)

As of 05:06 PM Eastern

SOS Limited provides data mining and analysis services to corporate and individual members in the People's Republic of China. It provides marketing data, technology, and solutions for insurance companies; emergency rescue services; and insurance product and health care information portals. The company operates SOS cloud emergency rescue service software as a service platform that offers basic cloud products, such as medical rescue, auto rescue, financial rescue, and life rescue cards; cooperative cloud systems, including information rescue center, intelligent big data, and intelligent software and hardware; and information cloud systems, such as newsToday and E-commerce Today, 10086 hot-line center, information security services, and marketing-related data. It also focuses on cryptocurrency mining, blockchain-based insurance, and security management businesses. The company serves insurance companies, financial institutions, medical institutions, healthcare providers, and other service providers in the emergency rescue services industry. The company is based in Qingdao, the People's Republic of China.

Ten-League International NASDAQ:TLIH

$5.73 -0.06 (-1.04%)

Closing price 03:55 PM Eastern

Extended Trading

$5.50 -0.23 (-4.01%)

As of 04:49 PM Eastern

Our mission is to provide high-quality equipment, value-added engineering solutions as well as maintenance and repair services through continuous adaptation and application of new technologies. We are a Singapore-based provider of turnkey project solutions. Our business primarily consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. We currently conduct our operations through our wholly-owned subsidiaries, Ten-League Engineering & Technology Pte. Ltd., or Ten-League (E&T), and Ten-League Port Engineering Solutions Pte. Ltd., or Ten-League (PES), which were previously held by Ten-League Corp prior to our group reorganization for the listing of our ordinary shares. Together with the operating history of Ten-League Corp, we have a total of over 25 years of history operating our business. Our core business activities consist of the following segments: (a) equipment sales, which involves sale of various new and used heavy equipment and parts, or Equipment Sales Business; (b) equipment rental, which involves the rental of various new and used heavy equipment, or Equipment Rental Business; and (c) engineering consultancy services, which primarily includes the provision of value-added engineering solutions, including equipment retrofitting, upgrading, modernization, fleet management and other enhancement on equipment through the replacement or application of, among others, mechanical parts, sensor fusion, software and remote control system. Our engineering consultancy services complements our Equipment Sales Business and Equipment Rental Business. We do not provide such service to third-party equipment sales/rental companies. The equipment we provide is categorized into (i) foundation equipment; (ii) hoist equipment; (iii) excavation equipment; and (iv) port machinery. We have been supplying fully electric reach stacker and empty container handler to port operators in Singapore since 2021 and have been contracted to supply electric prime movers with swappable battery pack and build charging infrastructure since October 2022 by a leading port operator based in Singapore, or the Leading Port Operator. Meanwhile, we are actively exploring the market for fully electric wheel loader, excavator and forklift, and offering them as a part of our fleet of electrified equipment. Our principal executive office is in Singapore.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BGMS, TLIH, SOS, and JBDI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BGMS, TLIH, SOS, and JBDI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BGMS, TLIH, SOS, and JBDI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BGMS, TLIH, SOS, and JBDI Company Descriptions

Cyclacel Pharmaceuticals NASDAQ:BGMS

JBDI NASDAQ:JBDI

SOS NYSE:SOS

Ten-League International NASDAQ:TLIH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BGMS, TLIH, SOS, and JBDI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BGMS, TLIH, SOS, and JBDI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BGMS, TLIH, SOS, and JBDI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

BGMS, TLIH, SOS, and JBDI Company Descriptions

Cyclacel Pharmaceuticals NASDAQ:BGMS

JBDI NASDAQ:JBDI

SOS NYSE:SOS

Ten-League International NASDAQ:TLIH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools